Main Article Content

Александр Викторович Мурзин
Оксана Александровна Мелкозерова
Елена Геннадьевна Дерябина

Abstract

Recent studies have shown that pregnancy resulting from the use of assisted reproductive technologies (ART) is associated with an increased risk of developing gestational diabetes mellitus (GDM). At the same time, GDM is an independent risk factor for a number of obstetric and perinatal complications. Does the method of conception matter in realizing the synergy of ART and GDM risk factors?

Purpose of the study – to study the role of assisted reproductive technologies in the development of obstetric and perinatal complications in patients with gestational diabetes mellitus.

Material and methods. An observational single-center retrospective cohort continuous study was carried out, the main group (n = 41) consisted of patients with pregnancy resulting from the use of ART, complicated by the development of GDM. The comparison group (n = 35) included patients with spontaneous pregnancy complicated by the development of GDM. The analysis of somatic and gynecological anamnesis, reproductive function was carried out, as well as perinatal complications and pregnancy outcomes in the study groups were analyzed.

Results. Patients with post-ART pregnancies complicated by GDM were significantly older than those with spontaneous pregnancies complicated by GDM (37 [34;40] years versus 27 [24;36] years); p = 0.00), their obstetric-gynecological history was significantly more often burdened (95.1 % (39/41) vs 45.7 % (16/35); p=0.000), they more often suffered from hypothyroidism (OR 5.325; 1.080–26.241; p = 0.031) and chronic diseases of the urinary system (OR 21.760; 2.704–175.09; p = 0.000). Prolonged use of progesterone preparations beyond 22 weeks of gestation (OR 11.917; 4.038–35.168; p = 0.000) is statistically significantly associated with the risk of GDM in patients after ART. Pregnancy resulting from ART and proceeding against the background of GDM significantly more often than spontaneous pregnancy with GDM was complicated by the development of moderate preeclampsia (OR 4.641; 0.930-23.158; p = 0.055), permanent threat of abortion (OR 3.529; 1.350–9.228 ; p = 0.009), the formation of fetal macrosomia (OR 3.911; 0.994–15.397; p = 0.041) and significantly more often ended with delivery by caesarean section (63.8 % (28/41) vs 28.6 % (10/35); p = 0.001).

Conclusions. The increase in the incidence of GDM among patients whose pregnancy occurred as a result of ART is associated with a later reproductive age, initially aggravated obstetric anamnesis and somatic pathology at the time of entry into the ART protocols, as well as long-term hormonal support of pregnancy after the use of ART from early pregnancy.

Keywords

assisted reproductive technologies, pregnancy high-risk, pregnancy complications, pregnancy outcome, gestational diabetes mellitus

Author Biographies

Александр Викторович Мурзин,
graduate student, junior researcher of the department antenatal fetus protection
Оксана Александровна Мелкозерова,
doctor of medical sciences, docent, deputy director for science
Елена Геннадьевна Дерябина,
doctor of medical sciences, the leading researcher of the department of the antenatal fetus protection

Article Details

Information about financing and conflict of interests

The study had no sponsorship.
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.

How to Cite

Мурзин, А. В., Мелкозерова, О. А., & Дерябина, Е. Г. (2023). GESTATIONAL DIABETES MELLITUS AFTER ART AND IN SPONTANEOUS PREGNANCY: DOES THE METHOD OF CONCEPTION MATTER IN THE IMPLEMENTATION OF OBSTETRIC AND PERINATAL COMPLICATIONS?. Mother and Baby in Kuzbass, 24(2), 42-49. https://doi.org/10.24412/2686-7338-2023-2-42-49

References

Korsak VS, Smirnova AA, Shurygina OV. ART Register of RAHR, 2020. Russian Journal of Human Reproduction. 2022; 28(6): 12-27. Russian (Корсак В.С., Смирнова А.А., Шурыгина О.В. Регистр ВРТ Общероссийской общественной организации «Российская Ассоциация Репродукции Человека». Отчет за 2020 год //Проблемы репродукции. 2022. Т. 28, № 6. С. 12-27.) doi: 10.17116/repro20222806112

Iakashvili SN. The course of pregnancy and delivery was the result of in vitro fertilization and embryo transfer. Modern problems of science and education. 2017; 3. Russian (Иакашвили С.Н. Особенности течения и исход одноплодной беременности, наступившей после экстракорпорального оплодотворения и переноса эмбриона, в зависимости от фактора бесплодия //Современные проблемы науки и образования. 2017. № 3.) doi: 10.17513/spno.26486

Koos BJ, Gornbein JA. Early pregnancy metabolites predict gestational diabetes mellitus: implications for fetal programming. Am J Obstet Gynecol. 2021; 224(2): 215.e1-215.e7. doi: 10.1016/j.ajog.2020.07.050

Bergh C, Wennerholm UB. Long-term health of children conceived after assisted reproductive technology. Upsala Journal of Medical Sciences. 2020; 125(2): 152-157. doi: 10.1080/03009734.2020.1729904

Maroufizadeh S, Navid B, Alizadeh A, Amini P, Almasi-Hashiani A, Mohammadi M. Risk of gestational diabetes mellitus following assisted reproductive technology: systematic review and meta-analysis of 59 cohort studies. The Journal of Maternal-Fetal & Neonatal Medicine. 2021; 34(16): 2731-2740. doi: 10.1080/14767058.2019.1670790

Wei W, He Y, Wang X, Tan G, Zhou F, Zheng G, et al. Gestational Diabetes Mellitus: The Genetic Susceptibility Behind the Disease. Horm Metab Res. 2021; 53(8): 489-498. doi: 10.1055/a-1546-1652

Szymanska M, Horosz E, Szymusik I, Bomba-Opon D, Wielgos M. Gestational diabetes in IVF and spontaneous pregnancies. Neuro Endocrinol Lett. 2011; 32(6): 885-888

American Diabetes Association. Gestational diabetes mellitus. Diabetes Care. 2004; 27: 88-90

Cunningham FG, Gant NF, Leveno KJ, Bloom SL, Spong CY, Dashe JS, et al. Williams Obstetrics. 22th ed., New York: McGraw-Hill, 2005

Kapustina MV, Petrukhin VA, Burumkulova FF, Dolgieva LU, Lukashenko SIu. In-vivo fertilization and gestational diabetes mellitus: a novel problem. Russian Bulletin of Obstetrician-Gynecologist. 2011; 11(1): 73-76. Russian (Капустина М.В., Петрухин В.А., Бурумкулова Ф.Ф., Долгиева Л.У., Лукашенко С.Ю. Экстракорпоральное оплодотворение и гестационный сахарный диабет: новая проблема //Российский вестник акушера-гинеколога. 2011. Т. 11, № 1. С. 73-76)

Arzhanova ON, Rulyova AV, Paykacheva YM, Ivanova AO, Nichiporuk NG. Risk of developing gestational diabetes in women after assisted reproductive technologies. Journal of Obstetrics and Women's Diseases. 2019; 68(2): 17-22. Russian (Аржанова О.Н., Рулева А.В., Пайкачева Ю.М., Иванова А.О., Ничипорук Н.Г. Риск развития гестационного сахарного диабета у пациенток после использования вспомогательных репродуктивных технологий //Журнал акушерства и женских болезней. 2019. Т. 68, № 2. С. 17-22.) doi: 10.17816/JOWD68217-22

Bosdou JK, Anagnostis P, Goulis DG, Lainas GT, Tarlatzis BC, Grimbizis GF, Kolibianakis EM. Risk of gestational diabetes mellitus in women achieving singleton pregnancy spontaneously or after ART: a systematic review and meta-analysis. Human Reproduction Update. 2020; 26(4): 514-544. doi: 10.1093/humupd/dmaa011

Ashrafi M, Gosili R, Hosseini R, Arabipoor A, Ahmadi J, Chehrazi M. Risk of gestational diabetes mellitus in patients undergoing assisted reproductive techniques. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2014; 176: 149-152. doi: 10.1016/j.ejogrb.2014.02.009

Clinical guidelines. Gestational diabetes [Electronic resource]. Moscow, 2020. Russian (Клинические рекомендации. Гестационный сахарный диабет [Электронный ресурс]. Москва, 2020.) Режим доступа: https://roag-portal.ru/recommendations_obstetrics

Order of the Ministry of Health of Russia dated October 20, 2020 N 1130n On approval of the Procedure for the provision of medical care in obstetrics and gynecology (Registered with the Ministry of Justice of Russia on November 12, 2020 N 60869) [Electronic resource]. Russian (Приказ Минздрава России от 20.10.2020 N 1130н Об утверждении Порядка оказания медицинской помощи по профилю акушерство и гинекология (Зарегистрировано в Минюсте России 12.11.2020 N 60869) [Электронный ресурс]) Режим доступа: https://sudact.ru/law/prikaz-minzdrava-rossii-ot-20102020-n-1130n

Fletcher R, Fletcher S, Vagner E. Clinical epidemiology. Fundamentals of evidence-based medicine. M.: Media Sfera, 1998. Russian (Флетчер Р., Флетчер С., Вагнер Э. Клиническая эпидемиология. Основы доказательной медицины. М.: Медиа Сфера, 1998)

Safarian GK, Gzgzyan AM, Dzhemlikhanova LK, Dariko NA. Does subclinical hypothyroidism and/or thyroid autoimmunity influence the IVF/ICSI outcome? Review of the literature. Gynecol Endocrinol. 2019; 35(1): 56-59. doi: 10.1080/09513590.2019.1653564

Bucci I, Giuliani C, Di Dalmazi G, Formoso G, Napolitano G. Thyroid Autoimmunity in Female Infertility and Assisted Reproductive Technology Outcome. Frontiers in Endocrinology. 2022; 13. doi: 10.3389/fendo.2022.768363

Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. Obstet Anesth Digest. 2009; 29(1): 39-40. doi: 10.1097/01.aoa.0000344706.95925.dc

Barden A, Singh R, Walters BN, Ritchie J, Roberman B, Beilin LJ. Factors predisposing to pre-eclampsia in women with gestational diabetes. Journal of Hypertension. 2004; 22(12): 2371-2378. doi: 10.1097/00004872-200412000-00020

Cavoretto P, Candiani M, Giorgione V, Inversetti A, Abu-Saba MM, Tiberio F, et al. Risk of spontaneous preterm birth in singleton pregnancies conceived after IVF/ICSI treatment: meta-analysis of cohort studies. Ultrasound in Obstetrics & Gynecology. 2018; 51(1): 43-53. doi: 10.1002/uog.18930

Clinical guidelines. Premature birth [Electronic resource]. Moscow, 2020. Russian (Клинические рекомендации. Преждевременные роды [Электронный ресурс]. Москва, 2020.) Режим доступа: https://roag-portal.ru/recommendations_obstetrics

Kapustin RV, Arzhanova ON, Bespalova ON. Exogenous progesterone as a factor for the development of gestational diabetes mellitus. Russian Bulletin of Obstetrician-Gynecologist. 2019; 19(1): 38-45. Russian (Капустин Р.В., Аржанова О.Н., Беспалова О.Н. Экзогенный прогестерон как фактор развития гестационного сахарного диабета //Российский вестник акушера-гинеколога. 2019. Т. 19, № 1. С. 38-45. doi: 10.17116/rosakush20191901138

Giannakou K, Evangelou E, Papatheodorou SI. Genetic and non-genetic risk factors for pre-eclampsia: umbrella review of systematic reviews and meta-analyses of observational studies. Ultrasound Obstetrics Gynecology. 2018; 51(6): 720-730. doi: 10.1002/uog.18959

Koos BJ, Hornbein JA. Metabolites of early pregnancy predict gestational diabetes mellitus: implications for fetal programming. Am J Obstet Gynecol. 2021; 224(2): 215.e1-215.e7. doi: 10.1016/j. jog.2020.07.050

Downloads

Download data is not yet available.

Most read articles by the same author(s)